Atlas Trials

Long-Term Assessment of Remyelinating Therapy

Clinical trial NCT02657915 · COMPLETED

Trial details

NCT number
NCT02657915
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Optic Neuritis
Start date
2016-03-10
Primary completion
2017-01-23
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.